Literature DB >> 20651391

An indication for correlation between the serum ADA level and gastric cancer risk.

Gyokuto Ri1, Satoshi Ohno, Michiko Furutani, Yoshiyuki Furutani, Tetsuo Tsukahara, Norihiro Hagita, Hiromi Haruyama, Shinichi Nakamura, Toshiyuki Yamamoto, Rumiko Matsuoka.   

Abstract

BACKGROUND: Gastric atrophy caused by Helicobacter pylori (H. pylori) infection is a risk factor for gastric cancer. We aimed to evaluate the relationship between gastric cancer risk and tumor markers in the general population.
MATERIALS AND METHODS: A total of 688 volunteers were examined to test their serum pepsinogen (PG) levels and anti-H. pylori antibodies, in addition to a total of 22 serum tumor markers. The participants were classified into four groups according to their anti-H. pylori antibody and serum PG serological status. Accordingly, groups A and D were negative, whereas groups B and C were positive for anti-H. pylori antibodies; and groups A and B were normal, whereas groups C and D were abnormal for serum PG levels. All the blood examination results were statistically evaluated using Student's t-test among these groups.
RESULTS: There were 424, 202, 50, and 12 individuals in groups A, B, C, and D, respectively. Because of the small number of participants in groups C and D, we combined these two groups. Compared to the normal group (A), a statistically significant higher in adenosine deaminase level was found in group C+D (p=0.01).
CONCLUSION: This result supports a previous study indicating that adenosine deaminase is involved in the regulatory system of chronic atrophic gastritis and gastric cancer risk.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20651391

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Effects of aqueous extract from Silybum marianum on adenosine deaminase activity in cancerous and noncancerous human gastric and colon tissues.

Authors:  Bahadır Öztürk; Ender Hilmi Kocaoğlu; Zahide Esra Durak
Journal:  Pharmacogn Mag       Date:  2015 Jan-Mar       Impact factor: 1.085

2.  Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.

Authors:  Vidya Nand Rabi Das; Sanjiva Bimal; Niyamat Ali Siddiqui; Ashish Kumar; Krishna Pandey; Sanjay Kumar Sinha; Roshan Kamal Topno; Vijay Mahentesh; Ashish Kumar Singh; Chandra Shekhar Lal; Subhankar Kumar Singh; Pradeep Das
Journal:  PLoS Negl Trop Dis       Date:  2020-06-18

3.  Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.

Authors:  Ajay Amit; Manas R Dikhit; Raj K Pandey; Kuljit Singh; Ritesh Mishra; V N R Das; Pradeep Das; Sanjiva Bimal
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.